Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01180894 · ClinicalTrials.gov registry record · NA
IV Iron for the Anemia of Traumatic Critical Illness
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT01180894 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 150 participants.
The verdict
NCT01180894, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.
Interventions
- DRUG Placebo
- DRUG Iron sucrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01180894
The ClinicalTrials.gov registry entry for NCT01180894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01180894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01180894 about?
NCT01180894 is a clinical study titled "IV Iron for the Anemia of Traumatic Critical Illness". The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.
What is the current status of trial NCT01180894?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2011-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01180894?
The interventions under investigation include: Placebo (DRUG), Iron sucrose (DRUG).
Who is sponsoring clinical trial NCT01180894?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.